Succesful CARE 4th Annual meeting

We just finished a super exciting 4th CARE annual meeting in Leiden, Netherlands.

Many thanks to the organizers from LUMC and Inserm Transfert, as well as to all participants for their great presentations and captivating discussions – this will inspire further acceleration of our most promising assets and research projects which will make a meaningful contribution to pandemic preparedness.

Many thanks also to the members of CARE’s Scientific and Ethics Advisory Board for great advice to CARE as it moves into its final phase before concluding in March 2025.

CARE convenes for its 4th Annual meeting on March 12-13

What happened in CARE in the past few months? The CARE partners will have the opportunity to discover and discuss the latest news, endeavours and achievements in the upcoming annual meeting (already the fourth one) that will be held in Leiden, NL, on March 12-13. With CARE entering its last year, this meeting will be of critically importance to plan the final stage of this project to ensure the best outcomes from these five years of collaborative work.

CARE Partner perspectives – Yves Lévy

The Covid-19 pandemic is over so what is the value of CARE? Principal investigators comment on CARE’s importance for future pandemic preparedness. Today, see the response from Yves Lévy, Inserm-Vaccine Research Institute, academic coordinator of CARE. 

CARE Partner perspectives – Cyril Dousson

The Covid-19 pandemic is over so what is the value of CARE? Principal investigators comment on CARE’s importance for future pandemic preparedness. Today, see the response from Cyril Dousson, CEO of Ai-biopharma

CARE – Infographic: What is CARE?

Do you need a quick overview of CARE? Check out this infographic for the key details of CARE at a glance.

The infographic is also available here

CARE 5th External Newsletter is now available

12 December 2024
CARE External Newsletter - June 2024 The new issue of our biannual newsletter is out. In this edition we learn an impressive app developed by AbbVie to determine genetic factors related to COVID-19 risk, plus we share news of an exciting partnership between University of Dundee and Novartis. We also introduce CARE partner Scifeon and the [...]